7 results · 13ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Olympus Endoscopic Flushing Pump, Model/Catalog Number: OFP-2 (K10001141)

FDA Enforcement
Class II ·Ongoing·Olympus Corporation of the Americas·November 6, 2024

Jewel Precision Reusable Rigid Sterilization Container System. Model/Catalog Number: JP-24-6.

FDA Enforcement
Class II ·Ongoing·Jewel Precision Sheet Metal & Machining Co, Inc.·July 2, 2025

Jewel Precision Reusable Rigid Sterilization Container System. Model Number: JP-24-8.

FDA Enforcement
Class II ·Ongoing·Jewel Precision Sheet Metal & Machining Co, Inc.·July 2, 2025

Product Name: HIGH FLOW INSUFFLATION TUBING (with Filter) Model/Catalog Number: 20400161S Product Description: Laparoscopic Insufflator

FDA Enforcement
Class II ·Ongoing·Canadian Hospital Specialties Ltd.·July 24, 2024

microTargeting Insertion Tube Set, P/N 66-IT-05P, Lot 244517. The intended use is to accurately guide a microelectrode or instrument in the brain during stereotactic functional neurosurgical procedures.

FDA Enforcement
Class I ·Ongoing·FHC, Inc.·November 20, 2024

17-OH Progesterone ELISA 96 well kit- An enzyme immunoassay for the quantitative in vitro diagnostic measurement of 17-OH Progesterone (17-OHP) in serum or plasma Model/Catalog Number: EIA-1292

FDA Enforcement
Class III ·Ongoing·DRG International, Inc.·November 6, 2024

Brand Name: STA Liatest D-Di Product Name: STA Liatest D-Di Model/Catalog Number: REF 00515 Product Description: The STA¿ - Liatest ¿ D-Di kit is an immuno-turbidimetric assay for the quantitative determination of D-dimer in venous plasma (in 3.2 % sodium citrate) for use on STA-R¿, STA Compact¿ and STA Satellite¿ analyzers by professional laboratory personnel. The STA¿ - Liatest¿ D-Di is intended for use in conjunction with a clinical pretest probability (PTP) assessment model to exclude pulmonary embolism (PE) and deep venous thrombosis (DVT) in outpatients suspected of PE or DVT. Component: No

FDA Enforcement
Class II ·Ongoing·Diagnostica Stago, Inc.·March 25, 2026